K-numberK252436
Device nameTula Tympanostomy Tube Delivery Device
ApplicantTusker Medical, Inc.
Product codeETD
Device classClass II
Decision dateApr 23, 2026
DecisionSubstantially Equivalent
Regulation874.3880
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Tula Tympanostomy Tube Delivery Device is a single-use, handheld device that creates a myringotomy (opening in the eardrum) and delivers a pre-loaded tympanostomy tube through the tympanic membrane in a single automated action lasting less than 500 milliseconds. It is indicated for use in office or operating room settings to treat pediatric patients aged 6 months and older and adult patients.

Technological characteristics

The subject device uses an automated operation mechanism with a stainless steel shaft and transparent polycarbonate tip, compared to the predicate device's manual mechanism. Both devices have the same pre-loaded tube design, principles of operation, materials (medical-grade silicone), sterilization method (ethylene oxide), and biocompatibility. The subject device expands the indication to include operating room use and adult patients, whereas the predicate was limited to office settings and pediatric patients.

Test standards cited

Biocompatibility testing per ISO 10993-1 and FDA Guidance on biological evaluation of medical devices. The sterilization method achieves a minimum sterility assurance level (SAL) of 10⁻⁶ via ethylene oxide gas, previously approved for a PMA device. Quality Management System Regulation (21 CFR Part 820) requirements including ISO 13485 design controls, nonconforming product, corrective action, and preventative action provisions.

Substantial equivalence argument

The subject device is substantially equivalent because it has the same intended use and principle of operation as the predicate (Hummingbird Tympanostomy Tube System, K221254), utilizes similar biocompatible materials, and demonstrates comparable clinical performance with high procedural success rates (87.4% in pivotal study) and no device-related serious adverse events. Although technological differences exist (automated vs. manual mechanism, expanded indications), these differences do not raise new safety or effectiveness questions and are consistent with the reference device (Tula TDS, K171239) previously cleared under K171239.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →